Prestige Consumer Healthcare Inc. (PBH)
USD 84.19
(2.38%)
USD 84.19
(2.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 373.1 Million USD | 2535.6% |
| 2023 | 14.18 Million USD | 4.75% |
| 2022 | 351.61 Million USD | 9.74% |
| 2021 | 310.38 Million USD | 3.16% |
| 2020 | 325.49 Million USD | -2.55% |
| 2019 | 327.45 Million USD | 31.05% |
| 2018 | 355.72 Million USD | -11.91% |
| 2017 | 304.45 Million USD | -0.26% |
| 2016 | 266.18 Million USD | 26.07% |
| 2015 | 226.52 Million USD | 11.49% |
| 2014 | 183.87 Million USD | -1.45% |
| 2013 | 203.68 Million USD | 80.61% |
| 2012 | 113.22 Million USD | 31.68% |
| 2011 | 85.95 Million USD | -9.04% |
| 2010 | 84.63 Million USD | 1.5% |
| 2009 | -156.16 Million USD | -11.23% |
| 2008 | 105.43 Million USD | -2.84% |
| 2007 | 94.68 Million USD | 1.57% |
| 2006 | 83.9 Million USD | -19.92% |
| 2005 | 103.1 Million USD | 499.03% |
| 2004 | 22.23 Million USD | -31.89% |
| 2003 | 32.64 Million USD | 72.33% |
| 2002 | 18.94 Million USD | 288.87% |
| 2001 | 4.87 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 93.79 Million USD | -3.54% |
| 2024 Q4 | 89.99 Million USD | -4.05% |
| 2024 FY | - USD | -1.32% |
| 2024 Q1 | 93.97 Million USD | 133.94% |
| 2024 Q2 | 93.69 Million USD | 5.7% |
| 2023 Q2 | 91.82 Million USD | -2.91% |
| 2023 FY | - USD | 4.75% |
| 2023 Q4 | 95.68 Million USD | 1.61% |
| 2023 Q3 | 94.16 Million USD | 2.55% |
| 2023 Q1 | 94.57 Million USD | 13.09% |
| 2022 Q3 | 90.46 Million USD | 5.16% |
| 2022 FY | - USD | 9.74% |
| 2022 Q1 | 99.04 Million USD | 27.69% |
| 2022 Q2 | 86.02 Million USD | -13.14% |
| 2022 Q4 | 83.63 Million USD | -7.56% |
| 2021 Q2 | 80.71 Million USD | -7.86% |
| 2021 Q3 | 81.42 Million USD | 0.88% |
| 2021 Q1 | 87.6 Million USD | 10.53% |
| 2021 FY | - USD | 3.16% |
| 2021 Q4 | 77.56 Million USD | -4.74% |
| 2020 Q2 | 75.74 Million USD | -3.11% |
| 2020 Q4 | 79.25 Million USD | -6.33% |
| 2020 FY | - USD | -2.55% |
| 2020 Q1 | 78.17 Million USD | -5.5% |
| 2020 Q3 | 84.61 Million USD | 11.71% |
| 2019 Q4 | 82.72 Million USD | -2.96% |
| 2019 Q3 | 85.24 Million USD | 10.24% |
| 2019 Q2 | 77.33 Million USD | -4.38% |
| 2019 Q1 | 80.87 Million USD | 613.08% |
| 2019 FY | - USD | 31.05% |
| 2018 Q4 | -15.76 Million USD | -117.14% |
| 2018 FY | - USD | -11.91% |
| 2018 Q1 | 87.6 Million USD | 45.94% |
| 2018 Q2 | 84.77 Million USD | -3.23% |
| 2018 Q3 | 91.96 Million USD | 8.48% |
| 2017 Q4 | 60.02 Million USD | -16.37% |
| 2017 FY | - USD | -0.26% |
| 2017 Q3 | 71.78 Million USD | -6.92% |
| 2017 Q2 | 77.12 Million USD | 303.71% |
| 2017 Q1 | 19.1 Million USD | -73.3% |
| 2016 Q2 | 75.61 Million USD | 10.79% |
| 2016 Q4 | 71.53 Million USD | 4.06% |
| 2016 Q3 | 68.74 Million USD | -9.09% |
| 2016 FY | - USD | 26.07% |
| 2016 Q1 | 68.25 Million USD | 1.8% |
| 2015 FY | - USD | 11.49% |
| 2015 Q3 | 62.16 Million USD | 23.38% |
| 2015 Q1 | 45.79 Million USD | -5.09% |
| 2015 Q2 | 50.38 Million USD | 10.02% |
| 2015 Q4 | 67.04 Million USD | 7.84% |
| 2014 Q2 | 57.08 Million USD | 8.29% |
| 2014 Q4 | 48.25 Million USD | 9.37% |
| 2014 Q3 | 44.11 Million USD | -22.71% |
| 2014 FY | - USD | -1.45% |
| 2014 Q1 | 52.71 Million USD | -1.4% |
| 2013 Q3 | 50.08 Million USD | -8.02% |
| 2013 FY | - USD | 80.61% |
| 2013 Q4 | 53.46 Million USD | 6.74% |
| 2013 Q2 | 54.45 Million USD | 15.54% |
| 2013 Q1 | 47.13 Million USD | 83.95% |
| 2012 Q4 | 25.62 Million USD | -2.19% |
| 2012 Q1 | 29.78 Million USD | 40.74% |
| 2012 Q2 | 31.97 Million USD | 7.34% |
| 2012 FY | - USD | 31.68% |
| 2012 Q3 | 26.19 Million USD | -18.07% |
| 2011 Q2 | 26.34 Million USD | 10.37% |
| 2011 Q1 | 23.86 Million USD | -56.19% |
| 2011 Q4 | 21.16 Million USD | 36.22% |
| 2011 Q3 | 15.53 Million USD | -41.02% |
| 2011 FY | - USD | -9.04% |
| 2010 Q2 | 13.72 Million USD | 24.71% |
| 2010 Q4 | 54.47 Million USD | 103.47% |
| 2010 FY | - USD | 1.5% |
| 2010 Q1 | 11 Million USD | 104.87% |
| 2010 Q3 | 26.77 Million USD | 95.0% |
| 2009 Q2 | 23.79 Million USD | -3.24% |
| 2009 Q3 | 23.25 Million USD | -2.25% |
| 2009 FY | - USD | -11.23% |
| 2009 Q4 | -226.11 Million USD | -1072.16% |
| 2009 Q1 | 24.59 Million USD | -13.01% |
| 2008 Q4 | 28.27 Million USD | 7.17% |
| 2008 Q2 | 24.14 Million USD | -9.35% |
| 2008 Q3 | 26.38 Million USD | 9.25% |
| 2008 Q1 | 26.63 Million USD | 1.58% |
| 2008 FY | - USD | -2.84% |
| 2007 Q1 | 26.58 Million USD | 12.36% |
| 2007 Q2 | 27.36 Million USD | 2.91% |
| 2007 Q3 | 28.15 Million USD | 2.88% |
| 2007 Q4 | 26.22 Million USD | -6.85% |
| 2007 FY | - USD | 1.57% |
| 2006 Q1 | 20.12 Million USD | -61.82% |
| 2006 Q4 | 23.66 Million USD | -16.02% |
| 2006 Q2 | 24.07 Million USD | 19.63% |
| 2006 Q3 | 28.17 Million USD | 17.05% |
| 2006 FY | - USD | -19.92% |
| 2005 Q1 | 31.63 Million USD | 0.0% |
| 2005 Q2 | 43.5 Million USD | 37.52% |
| 2005 FY | - USD | 499.03% |
| 2005 Q3 | 28.97 Million USD | -33.39% |
| 2005 Q4 | 52.7 Million USD | 81.89% |
| 2004 FY | - USD | -31.89% |
| 2003 FY | - USD | 72.33% |
| 2002 FY | - USD | 288.87% |
| 2001 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cardinal Health, Inc. | 1.97 Billion USD | 81.137% |
| Cencora | 3.25 Billion USD | 88.53% |
| McKesson Corporation | 4.66 Billion USD | 92.005% |
| Owens & Minor, Inc. | 400.28 Million USD | 6.791% |